U.S. Medical Cannabis Market Continues to Grow

U.S. Medical Cannabis Market Continues to Grow

SARASOTA, Fla.--(BUSINESS WIRE)-- As Neutra Corp. (OTCBB: NTRR), a growing provider of all-natural wellness solutions, works to market and develop new horticultural and delivery systems for medicinal cannabis, the market continues to grow in the U.S. This month, Oregon became the latest state to authorize medical marijuana (MMJ) dispensaries.

Gov. John Kitzhaber signed a bill earlier this month allowing retailers to reimburse growers and charge for their product, and provides for a registry for businesses providing such services. Oregon voters initially approved a statewide initiative in 1998 mandating state lawmakers to allow for physicians to authorize qualified patients to consume and grow cannabis.

Twenty states as well as the District of Columbia have now approved the use of medical marijuana, with more expected to follow. As part of an ambitious strategy to gain market share in a sector forecast to reach $6 billion over the next five years, NTRR has initiated development on a horticultural post-production system alongside partners Vertigo Technologies that could soon revolutionize the time and care needed to deliver medicinal cannabis to patients.

The company has also begun research and development activities on a new cutting-edge oral delivery system for nutraceuticals including MMJ.

By providing innovative nutraceutical products and services such as new MMJ breakthroughs, Neutra Corp. plans to follow in the footsteps of other successful public companies including Cannabis Science, Inc. (OTCBB: CBIS), Medical Marijuana Inc. (OTCBB: MJNA) and Terra Tech Corp. (OTCBB: TRTC), delivering technological advancements in the cultivation and processing of cannabis in approved markets.

For more information on NTRR's initiatives, please visit www.neutracorp.com.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Neutra Corp.
Sydney Jim, 813-367-2041
President and CEO

KEYWORDS: United States North America Florida Oregon


The article U.S. Medical Cannabis Market Continues to Grow originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.